Hydrogen/Deuterium Exchange
Skip Navigation Links
Home
About Us
Therapeutic Focus
Technology
News and Publications
Careers
Contact Us
 
H/D Exchange
 
Skip Navigation LinksExSAR Home > About Us > Board of Directors > Myra Williams, Ph.D.
Myra Williams, Ph.D.
Dr. Williams served most recently as President and CEO of Molecular Applications Group, a bioinformatics company that developed proprietary technology to predict gene and protein function for use in pharmaceutical and agricultural product discovery. Previously, Dr. Williams was Vice President of Worldwide R & D Information Resources for Glaxo Wellcome plc and Vice President and Chief Information Officer of Glaxo, Inc. She served in an executive capacity at Merck Research Laboratories for over twenty years, including several years as the Executive Director of Information Resources and Strategic Planning. Dr. Williams is a member of the Boards of Directors of a number of companies, and is a consultant to venture capital, pharmaceutical, biotechnology and software companies.

Company Profile (History) | Senior Management Team | Board of Directors | Scientific Advisory Board
Robert F. Johnston - Chairman of the Board | Charles R. Cantor, Ph.D. | Myra Williams, Ph.D. | Arnold Levine, Ph.D. | Bijan Almassian, Ph.D.


Epitope Mapping
  Hydrogen/Deuterium Exchange Mass Spectrometry (HDMX)
 
Home   |   About Us   |   Therapeutic Focus   |   Technology   |   News and Publications   |   Careers   |   Contact Us   |   Sitemap
ExSAR is a trademark of ExSAR Corporation. Content © 2008 ExSAR Corporation. Terms of Use © 2008
11 Deer Park Drive, Suite 103   |   Monmouth Junction, New Jersey 08852   |   Phone: (732) 438-6500   |   Fax: (732) 438-1919
Optimized for resolutions of 1024 x 768 or higher with Microsoft Internet Explorer 6.0 or later
Web Site Designed and Maintained by Stonehouse Media Incorporated©